The recent approval of Kynamro for the treatment of homozygous familial hypercholesterolemia marked a critical step in the final validation of the siRNA technology. Join scientists from all over the world to discuss your latest research on siRNA.
This is an online event.
How it works:Create a profile describing your professional background to introduce yourself to other attendees.Request one-on-one meetings with other attendees.Accept requests from attendees that have expressly requested to speak with you.Start a one-on-one discussion over live videoSay 'Thank You' when you're ready to speak with someone new.
Benefits of attending:Initiate deals and partnershipsBoost your careerDeepen or widen your knowledge in the fieldMeet relevant professionals
To learn more, visit Askapeer. General Admission 0.00